Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Sep 15, 2026
4 Sep 14, 2026 FORM 4
4 Sep 14, 2026 FORM 4
4 Sep 14, 2026 FORM 4
4 Sep 14, 2026 FORM 4
4 Sep 14, 2026 FORM 4
4 Sep 10, 2026 FORM 4
144 Sep 8, 2026
8-K Sep 8, 2026 8-K
4 Sep 1, 2026 FORM 4
144 Aug 28, 2026
8-K Aug 28, 2026 8-K
8-K Aug 27, 2026 8-K
4 Aug 24, 2026 FORM 4
4 Aug 24, 2026 FORM 4
4 Aug 21, 2026 FORM 4
144 Aug 21, 2026
144 Aug 20, 2026
144 Aug 19, 2026
4 Aug 18, 2026
144 Aug 18, 2026
144 Aug 17, 2026
144 Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 6, 2026 10-Q
← Newer Page 2 of 40 · 988 filings Older →